blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3691632

EP3691632 - COMPOSITIONS, METHODS, SYSTEMS AND/OR KITS FOR PREVENTING AND/OR TREATING NEOPLASMS [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  13.03.2024
Database last updated on 11.09.2024
FormerExamination is in progress
Status updated on  11.11.2022
FormerRequest for examination was made
Status updated on  10.07.2020
FormerThe international publication has been made
Status updated on  13.04.2019
Most recent event   Tooltip07.08.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
Research Cancer Institute of America
1680 E. Herndon Ave. 102
Fresno, California 93720 / US
[2020/33]
Inventor(s)01 / NEZAMI, Mohammed, Amin
1680 E. Herndon Ave.
102
Fresno CA 93720 / US
 [2020/33]
Representative(s)Zacco Sweden AB
P.O. Box 5581
Löjtnantsgatan 21
114 85 Stockholm / SE
[N/P]
Former [2020/33]Zacco Sweden AB
P.O. Box 5581
114 85 Stockholm / SE
Application number, filing date18863859.705.10.2018
[2020/33]
WO2018US54753
Priority number, dateUS201762569413P06.10.2017         Original published format: US 201762569413 P
[2020/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019071229
Date:11.04.2019
Language:EN
[2019/15]
Type: A1 Application with search report 
No.:EP3691632
Date:12.08.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 11.04.2019 takes the place of the publication of the European patent application.
[2020/33]
Search report(s)International search report - published on:US11.04.2019
(Supplementary) European search report - dispatched on:EP23.04.2021
ClassificationIPC:A61K31/353, A61K36/82, A61P35/04, A61K9/51, A61K31/495, A61K31/352
[2024/12]
CPC:
A61P35/04 (EP); A61K9/513 (US); A61K31/192 (EP,US);
A61K31/352 (EP); A61K31/353 (EP,US); A61K31/495 (EP,US);
A61K45/06 (EP); A61K9/5146 (EP); A61K9/5153 (EP);
A61P35/00 (US); A61K9/0019 (EP) (-)
C-Set:
A61K31/192, A61K2300/00 (EP);
A61K31/352, A61K2300/00 (EP);
A61K31/353, A61K2300/00 (EP);
A61K31/495, A61K2300/00 (EP)
Former IPC [2021/21]A61K31/353, A61K36/82, A61P35/04, A61K9/51, A61K31/495
Former IPC [2020/33]A61K31/353, A61K36/82, A61P35/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/33]
TitleGerman:ZUSAMMENSETZUNGEN, VERFAHREN, SYSTEME UND/ODER KITS ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON NEOPLASMEN[2020/33]
English:COMPOSITIONS, METHODS, SYSTEMS AND/OR KITS FOR PREVENTING AND/OR TREATING NEOPLASMS[2020/33]
French:COMPOSITIONS, MÉTHODES, SYSTÈMES ET/OU KITS DE PRÉVENTION ET/OU DE TRAITEMENT DE NÉOPLASMES[2020/33]
Entry into regional phase03.04.2020National basic fee paid 
03.04.2020Search fee paid 
03.04.2020Designation fee(s) paid 
03.04.2020Examination fee paid 
Examination procedure03.04.2020Examination requested  [2020/33]
16.11.2021Amendment by applicant (claims and/or description)
10.11.2022Despatch of a communication from the examining division (Time limit: M04)
07.03.2023Reply to a communication from the examining division
14.09.2023Despatch of a communication from the examining division (Time limit: M02)
22.09.2023Reply to a communication from the examining division
14.03.2024Communication of intention to grant the patent
06.08.2024Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
Fees paidRenewal fee
04.05.2020Renewal fee patent year 03
29.09.2021Renewal fee patent year 04
15.09.2022Renewal fee patent year 05
13.09.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2014091078  (FILANA LTD OY [FI], et al) [I] 1-15 * the whole document *;
 [A]WO2014111268  (ALTERGON SA [CH]) [A] 1-15* claim - *;
 [XI]  - GAO XIANG ET AL, "Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles", INTERNATIONAL JOURNAL OF NANOMEDICINE, AUCKLAND, NZ, doi:10.2147/IJN.S75550, ISSN 1176-9114, (20150316), page 2051, URL: https://doi.org/10.2147/IJN.S75550, (20210415), XP055795401 [X] 1,2,4,9-12,14 * the whole document * [I] 3,5-8,13,15

DOI:   http://dx.doi.org/10.2147/IJN.S75550
International search[A]WO2007121088  (NOVARTIS AG [CH], et al) [A] 1-2, 3/1-2, 10/3/1-2* ; entire document *;
 [X]US2013011488  (NEZAMI MD MOHAMMAD [US]) [X] 1-2, 3/1-2, 10/3/1-2 * ; paragraphs [0004], [0006], [0035] *
by applicantWO2014091078
 US9308270
    - MOUSA S.A.BHARALI D.J., "Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications", Cancers (Basel, (20110900), vol. 3, no. 3, pages 2888 - 2903
    - MOUSA S.A., "Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise", Pharmacology & Therapeutics, (20101100), vol. 128, no. 2, doi:10.1016/j.pharmthera.2010.07.007, pages 324 - 335, XP055099250

DOI:   http://dx.doi.org/10.1016/j.pharmthera.2010.07.007
    - BHARALI D.J. et al., "Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers", International Journal of Nanomedicine, (20090401), vol. 4, pages 1 - 7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.